Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Roundhill NVDA WeeklyPay ETF (NVDW) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance

Roundhill NVDA WeeklyPay ETFTrade
Relay Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Roundhill NVDA WeeklyPay ETF vs Relay Therapeutics Inc. Common Stock — how do they compare? Roundhill NVDA WeeklyPay ETF trades at $37.15 (market cap $119.10M), while Relay Therapeutics Inc. Common Stock trades at $18.27 (market cap $3.82B). The key difference: Relay Therapeutics Inc. Common Stock is far larger — about 32.1× Roundhill NVDA WeeklyPay ETF's market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, Roundhill NVDA WeeklyPay ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Roundhill NVDA WeeklyPay ETF for 50 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.

NVDWRLAY
Market Cap
$119.10M$3.82B
Volume
44,8384,332,079
Sector
Income / Options OverlayHealth
52-Week High
$52.33$20.75
52-Week Low
$31.88$6.03
Typical Hold Time
50 Days0 Days
Enterprise Value
—$2.93B

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NVDW
7% Buy93% Sell
Avg holding period · 50 Days
RLAY
100% Buy0% Sell
Avg holding period · 0 Days

About Roundhill NVDA WeeklyPay ETF

NVDW is an actively managed ETF that seeks to provide weekly distributions and returns equal to 1.2 times (120%) the calendar week performance of Nvidia (NVDA) common shares. It combines modest leverage with a high-frequency payout schedule, designed for investors who want amplified exposure to Nvidia alongside a consistent weekly income stream.

Read more on NVDW →

About Relay Therapeutics Inc. Common Stock

Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.

Read more on RLAY →